Lyra Therapeutics, Inc. (LYRA) NASDAQ

8.65

-0.415(-4.58%)

Updated at July 11 04:00PM

Currency In USD

Valuation

Market Cap671.98M
Enterprise Value665.78M
P/E Ratio-7.15
PEG Ratio-0.41
Price/Sales Ratio11.66
Price/Book Ratio146.82
Enterprise/Revenue13.03
Enterprise/EBITDA-0.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-67.11
Operating Margin-68.92

Management Effectiveness

Return On Assets-1.41
Return On Equity-4.74

Income Statement

Revenue1.53M
Revenue/Share0.02
Gross Profit1.06M
EBITDA-60.26M
Net Income-93.44M
Diluted EPS0

Balance Sheet

Total Cash31.74M
Total Cash/Share0.48
Total Debt33.36M
Total Debt/Equity8.61
Current Ratio2.96
Book Value Per Share0.06

Price History

52-Week Change-43.31
52-Week High37.5
52-Week Low3.81
Moving Average 50 Days9.71
Moving Average 200 Days9.66

Statistics

Average Volume708,956
Shares Outstanding1.6M
% Held by Institutions38.92

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 28, 2025